Credit Agricole’s Catalyst Pharmaceutical CPRX Stock Holding History

Credit Agricole’s Portfolio CPRX Stock Details CPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.09M	Buy	+44,000	New	+$1.05M	﹤0.01%	1056
2025 Q1	$2.08M	Hold	85,761	–	–	0.01%	737
2024 Q4	$1.79M	Buy	85,761 +57,642	+205%	+$1.24M	0.01%	768
2024 Q3	$559K	Buy	+28,119	New	+$521K	﹤0.01%	924
2022 Q1	–	Sell	-10,000	Closed	-$68K	–	717
2021 Q4	$68K	Hold	10,000	–	–	﹤0.01%	501
2021 Q3	$53K	Hold	10,000	–	–	﹤0.01%	500
2021 Q2	$58K	Hold	10,000	–	–	﹤0.01%	479
2021 Q1	$46K	Hold	10,000	–	–	﹤0.01%	456
2020 Q4	$33K	Buy	+10,000	New	+$33.6K	﹤0.01%	424

Other funds holding CPRX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Credit Agricole's CPRX Position: Q1 2026 in Review

Credit Agricole opened a new position in Catalyst Pharmaceutical (CPRX) in Q1 2026: 44,000 shares worth $1.09M. The stake represents ﹤0.01% of the portfolio and ranks #1056 among its holdings. This is a return to the name: Credit Agricole previously reported a position in CPRX as recently as Q1 2025.

Credit Agricole first reported a position in CPRX in Q4 2020 and has held it in 9 quarters since. The position peaked at $2.08M in Q1 2025. 380 funds tracked by Wall St. Rank hold CPRX as of Q1 2026.

Credit Agricole held 44,000 shares of Catalyst Pharmaceutical worth $1.09M as of Q1 2026.
Catalyst Pharmaceutical was a new Credit Agricole position in Q1 2026.
Catalyst Pharmaceutical made up ﹤0.01% of Credit Agricole's portfolio in Q1 2026, its #1056 holding.
Credit Agricole first reported a position in Catalyst Pharmaceutical in Q4 2020 and has held it in 9 quarters since.
Credit Agricole's Catalyst Pharmaceutical position peaked at $2.08M in Q1 2025.
380 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q1 2026.

Based on Credit Agricole's 13F filing for Q1 2026, filed 15 May 2026.